scispace - formally typeset
R

Roelinde Middelveld

Researcher at Karolinska Institutet

Publications -  59
Citations -  2053

Roelinde Middelveld is an academic researcher from Karolinska Institutet. The author has contributed to research in topics: Asthma & Food allergy. The author has an hindex of 21, co-authored 57 publications receiving 1612 citations. Previous affiliations of Roelinde Middelveld include Örebro University & University of Stirling.

Papers
More filters
Journal ArticleDOI

Clinical and inflammatory characteristics of the European U-BIOPRED adult severe asthma cohort

Dominick E. Shaw, +56 more
TL;DR: U-BIOPRED is characterised by poor symptom control, increased comorbidity and airway inflammation, despite high levels of treatment, and is well suited to identify asthma phenotypes using the array of "omic" datasets that are at the core of this systems medicine approach.
Journal ArticleDOI

U-BIOPRED clinical adult asthma clusters linked to a subset of sputum omics

Diane Lefaudeux, +222 more
TL;DR: Clustering based on clinicophysiologic parameters yielded 4 stable and reproducible clusters of asthmatic patients that associate with different pathobiological pathways.
Journal ArticleDOI

Increased Prevalence of Symptoms of Rhinitis but Not of Asthma between 1990 and 2008 in Swedish Adults: Comparisons of the ECRHS and GA2LEN Surveys

TL;DR: From 1990 to 2008 the prevalence of obstructive airway symptoms common in asthma did not increase in Swedish young adults, which supports the few available international findings suggesting the previous upward trend in asthma has recently reached a plateau.
Journal Article

Frequent exacerbators – A distinct phenotype of severe asthma

TL;DR: In this article, the authors evaluated risk factors for frequent exacerbations (defined as either ≥2 or ≥3 events/year) and identified factors associated with a higher risk of exacerbations.
Journal ArticleDOI

Assessment of problematic severe asthma in children

TL;DR: The lack of good data and the heterogeneity of problematic severe asthma still limit the ability to optimise the management on an individual basis in this small, but challenging group of patients.